Cargando…

Pharmacological Pain Treatment in 2012 and 2017 Among Older People with Major Neurocognitive Disorder

BACKGROUND AND OBJECTIVE: Pain is highly prevalent among older people, and treatment is complicated because of comorbidities and polypharmacy. Among people with major neurocognitive disorder additional difficulties might arise. The aim of this study was to describe analgesic drug use in 2012 and 201...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gustafsson, Maria, Lövheim, Hugo, Sjölander, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593018/ https://www.ncbi.nlm.nih.gov/pubmed/34664213 http://dx.doi.org/10.1007/s40266-021-00897-9

Ejemplares similares

Psychotropic drug use among older people with major neurocognitive disorder: a cross-sectional study based on Swedish national registries
por: Kindstedt, Jonas, et al.
Publicado: (2021)

Potentially Inappropriate Medications Pre- and Post-Diagnosis of Major Neurocognitive Disorders Among Older People in Sweden: A Register-Based, 6-Year Longitudinal Study
por: Sönnerstam, Eva, et al.
Publicado: (2022)

Prevalence of potentially inappropriate medications among old people with major neurocognitive disorder in 2012 and 2017
por: Rangfast, Iris, et al.
Publicado: (2022)

Clinically relevant drug–drug interactions among elderly people with dementia
por: Sönnerstam, Eva, et al.
Publicado: (2018)

Prevalence of Drugs and Drug Combinations that Increase Risk of Prolonged QT Time Among People with Major Neurocognitive Disorder Living in Sweden: A Cross-Sectional Registry Study
por: Gustafsson, Maria, et al.
Publicado: (2022)

Prevalence of pain and pharmacological pain treatment among old people in nursing homes in 2007 and 2013
por: Hemmingsson, Eva-Stina, et al.
Publicado: (2017)

Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia: a randomized controlled trial
por: Gustafsson, Maria, et al.
Publicado: (2017)

Effects of Pharmacists’ Interventions on Inappropriate Drug Use and Drug-Related Readmissions in People with Dementia—A Secondary Analysis of a Randomized Controlled Trial
por: Gustafsson, Maria, et al.
Publicado: (2018)

Potentially inappropriate medications in relation to length of nursing home stay among older adults
por: Sönnerstam, Eva, et al.
Publicado: (2022)

Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units
por: Gustafsson, Maria, et al.
Publicado: (2013)

Investigating the effect of clinical pharmacist intervention in transitions of care on drug-related hospital readmissions among the elderly: study protocol for a randomised controlled trial
por: Kindstedt, Jonas, et al.
Publicado: (2020)

Psychotropic drug use among people with dementia – a six-month follow-up study
por: Gustafsson, Maria, et al.
Publicado: (2013)

Pharmacologic management of behavioral and psychological symptoms of major neurocognitive disorder
por: Mathys, Monica
Publicado: (2018)

Constipation and laxative use among people living in nursing homes in 2007 and 2013
por: Gustafsson, Maria, et al.
Publicado: (2019)

Inappropriate Prescription and Renal Function Among Older Patients with Cognitive Impairment
por: Sönnerstam, Eva, et al.
Publicado: (2016)

Oropharyngeal dysphagia and associated factors among individuals living in nursing homes in northern Sweden in 2007 and 2013
por: Hägglund, Patricia, et al.
Publicado: (2022)

An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list
por: Sönnerstam, Eva, et al.
Publicado: (2017)

An Innovative Non-Pharmacologic Treatment for Delusional Misidentification in Persons with Major Neurocognitive Disorder
por: Adams, Anne E., et al.
Publicado: (2021)

Use of heart failure medications in older individuals and associations with cognitive impairment
por: Abramsson, Linnea, et al.
Publicado: (2023)

Effect of Cognitive Training on Daily Function in Older People without Major Neurocognitive Disorder: A Systematic Review
por: Fan, Brian J.Y., et al.
Publicado: (2019)

Psychometric Properties of the Montreal Cognitive Assessment (MoCA) to Detect Major Neurocognitive Disorder Among Older People in Ethiopia: A Validation Study
por: Daniel, Beniam, et al.
Publicado: (2022)

Dysphoric symptoms in relation to other behavioral and psychological symptoms of dementia, among elderly in nursing homes
por: Lindbo, Agnes, et al.
Publicado: (2017)

The VITAAL Stepping Exergame Prototype for Older Adults With Major Neurocognitive Disorder: A Usability Study
por: Swinnen, Nathalie, et al.
Publicado: (2021)

Subjective experiences of neurocognitive functioning in young people with major depression
por: Morey-Nase, Catherine, et al.
Publicado: (2019)

Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease
por: Lucza, Tivadar, et al.
Publicado: (2015)

Validation of the Rowlands Universal Dementia Assessment Scale (RUDAS) to detect major neurocognitive disorder among elderly people in Ethiopia, 2020
por: Daniel, Beniam, et al.
Publicado: (2022)

Predictors of Major Depressive Disorder in Older People
por: Sousa, Susana, et al.
Publicado: (2021)

COVID-related confinement experience in people with major neurocognitive disorders and their caregivers in new aquitaine region, France
por: Calvet, B.
Publicado: (2021)

Neurocognitive Functioning in Patients with Painful Temporomandibular Disorders
por: Staniszewski, Kordian, et al.
Publicado: (2023)

Grip Strength, Neurocognition, and Social Functioning in People WithType-2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia
por: Aliño-Dies, María, et al.
Publicado: (2020)

Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders
por: Omeragic, Amila, et al.
Publicado: (2020)

A Systematic Review of Pharmacological Interventions for Apathy in Aging Neurocognitive Disorders
por: Theleritis, Christos, et al.
Publicado: (2023)

Memantine for the Treatment of Behavioral Disturbance in Unspecified Major Neurocognitive Disorder
por: Terry, Peyton H, et al.
Publicado: (2021)

Intelligence, cognition, and major neurocognitive disorders: From constructs to measures
por: Salvadori, Emilia
Publicado: (2023)

Pharmacological management of chronic non-cancer pain in frail older people
por: Wong, Gloria
Publicado: (2022)

Accuracy of three depression screening scales to diagnose major depressive episodes in older adults without neurocognitive disorders
por: Costa, Mônica V., et al.
Publicado: (2016)

Factors Associated With Cancer Worry Among People Aged 50 or Older, Spain, 2012–2014
por: Hidalgo, Jesús López-Torres, et al.
Publicado: (2015)

Characterizing neurocognitive impairment in young people with major depression: state, trait, or scar?
por: Allott, Kelly, et al.
Publicado: (2016)

Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients
por: Salvadori, Emilia, et al.
Publicado: (2018)

Costs for Statutorily Insured Dental Services in Older Germans 2012–2017
por: Krasowski, Aleksander, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eltin2q4omauem33lgs6vqrf92